194 related articles for article (PubMed ID: 36467799)
1. The value of leukapheresis for treatment of priapism as presenting feature of chronic myeloid leukemia-Case report and review of literature.
van der Velde MGAM; Tiellemans SMB; de Lil H; Nieuwenhuizen L
EJHaem; 2022 Nov; 3(4):1100-1115. PubMed ID: 36467799
[TBL] [Abstract][Full Text] [Related]
2. How I manage priapism in chronic myeloid leukaemia patients.
Rodgers R; Latif Z; Copland M
Br J Haematol; 2012 Jul; 158(2):155-164. PubMed ID: 22571386
[TBL] [Abstract][Full Text] [Related]
3. Priapism at Diagnosis of Pediatric Chronic Myeloid Leukemia: Data Derived from a Large Cohort of Children and Teenagers and a Narrative Review on Priapism Management.
Suttorp M; Sembill S; Kalwak K; Metzler M; Millot F
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510891
[TBL] [Abstract][Full Text] [Related]
4. Priapism in Patients with Chronic Myeloid Leukemia (CML): A Systematic Review.
Ali E; Soliman A; De Sanctis V; Nussbaumer D; Yassin M
Acta Biomed; 2021 Jul; 92(3):e2021193. PubMed ID: 34212918
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Leukocytapheresis to relieve priapism due to leukostasis in CML patients: Our experience in a tertiary care centre.
Sil S; Mohan AK; Negi G; Banerjee P; Kaur D; Mittal A; Jain A
Transfus Clin Biol; 2024 Feb; 31(1):36-40. PubMed ID: 37944664
[TBL] [Abstract][Full Text] [Related]
6. Priapism secondary to leukemia: effective management with prompt leukapheresis.
Ponniah A; Brown CT; Taylor P
Int J Urol; 2004 Sep; 11(9):809-10. PubMed ID: 15379953
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Priapism as The Clinical Presenting Feature of Chronic Myeloid Leukemia: Case Report and 20-Year Literature Review.
Bintoro SUY; Romadhon PZ; Suryantoro SD; Aminy RZ; Windradi C; Widiyastuti KN
F1000Res; 2021; 10():571. PubMed ID: 35087660
[TBL] [Abstract][Full Text] [Related]
8. Priapism as a Debut Presentation of Chronic Myeloid Leukemia.
Dhar J; Dhar J; Chhabra G; Khandelwal L; Khandelwal L; Batra A; Gupta N; Gupta N
J Coll Physicians Surg Pak; 2019 Jan; 29(1):78-80. PubMed ID: 30630577
[TBL] [Abstract][Full Text] [Related]
9. Effect of leukapheresis on pain reduction in leukemic priapism.
Noushad S; Sahoo D; Basavarajegowda A; Toora E; Paudel P
Asian J Transfus Sci; 2022; 16(1):124-127. PubMed ID: 36199404
[TBL] [Abstract][Full Text] [Related]
10. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
[TBL] [Abstract][Full Text] [Related]
11. High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasis.
Zhao J; Bewersdorf JP; Jaszczur S; Kowalski A; Perreault S; Schiffer M; Gore S; Podoltsev N; Prebet T; Shallis R; Zeidan AM
Leuk Lymphoma; 2021 May; 62(5):1195-1202. PubMed ID: 33325761
[TBL] [Abstract][Full Text] [Related]
12. Priapismus as Leukostasis Manifestation in Chronic Myeloid Leukemia.
Rajabto W; Djianzonie JAC; Pratisthita LB; Shatri H
Acta Med Indones; 2020 Oct; 52(4):420-422. PubMed ID: 33377887
[TBL] [Abstract][Full Text] [Related]
13. Leukostasis in Chronic Lymphocytic Leukemia.
Singh N; Singh Lubana S; Dabrowski L; Sidhu G
Am J Case Rep; 2020 Jul; 21():e924798. PubMed ID: 32616708
[TBL] [Abstract][Full Text] [Related]
14. Leukapheresis Does Not Improve Early Survival Outcome of Acute Myeloid Leukemia with Leukostasis Patients - A Dual-Center Retrospective Cohort Study.
Rinaldi I; Sari RM; Tedhy VU; Winston K
J Blood Med; 2021; 12():623-633. PubMed ID: 34290537
[TBL] [Abstract][Full Text] [Related]
15. Leukapheresis in management hyperleucocytosis induced complications in two pediatric patients with chronic myelogenous leukemia.
Veljković D; Kuzmanović M; Mićić D; Šerbić-Nonković O
Transfus Apher Sci; 2012 Jun; 46(3):263-7. PubMed ID: 22480956
[TBL] [Abstract][Full Text] [Related]
16. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
Shallis RM; Stahl M; Bewersdorf JP; Hendrickson JE; Zeidan AM
Expert Rev Hematol; 2020 May; 13(5):489-499. PubMed ID: 32248712
[No Abstract] [Full Text] [Related]
17. Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis.
Chen KH; Liu HC; Liang DC; Hou JY; Huang TH; Chang CY; Yeh TC
J Formos Med Assoc; 2014 Nov; 113(11):833-8. PubMed ID: 24534017
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic leukapheresis in hyperleukocytic leukaemias--the experience of a tertiary institution in Singapore.
Tan D; Hwang W; Goh YT
Ann Acad Med Singap; 2005 Apr; 34(3):229-34. PubMed ID: 15902342
[TBL] [Abstract][Full Text] [Related]
19. Leukostasis retinopathy: An uncommon visual threatening complication of chronic myeloid leukemia with severe hyperleukocytosis - A case report and review of the literature.
Chen B; Yan X; Zhang X; Yang H
Indian J Ophthalmol; 2018 Dec; 66(12):1871-1874. PubMed ID: 30451209
[TBL] [Abstract][Full Text] [Related]
20. Comparing leukapheresis protocols for an AML patient with symptomatic leukostasis.
Cline A; Jajosky R; Shikle J; Bollag R
J Clin Apher; 2018 Jun; 33(3):396-400. PubMed ID: 28940295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
